Faheem W Guirgis

Faheem W Guirgis, MD, FACEP

Associate Professor; Program Director, Emergency Medicine And Acute Care Research Fellowship

Department: Emergency Medicine – Jacksonville
Business Phone: (904) 244-4986
Business Email: faheem.guirgis@jax.ufl.edu

About Faheem W Guirgis

Dr. Faheem W. Guirgis, MD, FACEP is an Associate Professor of Emergency Medicine in the Department of Emergency Medicine at the University of Florida College of Medicine in Jacksonville. He received his medical degree from The Chicago Medical School at Rosalind Franklin University and his Emergency Medicine residency training at the Albert Einstein College of Medicine in the Bronx, NY. Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.

Board Certifications

  • Emergency Medicine
    American Board of Emergency Medicine

Clinical Profile

Specialties
  • Emergency Medicine

Research Profile

Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.

Open Researcher and Contributor ID (ORCID)

0000-0002-4445-3939

Publications

2017 Journal of Critical Care
2017 Journal of patient safety (Online)
2014 American Journal of Emergency Medicine

Grants

Jun 2020 ACTIVE
COVID:A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
LEIDOS · Principal Investigator
Apr 2020 ACTIVE
COVID-19: Angiotensin Receptor blockers for novel SAR-CoV-2
UNIV OF MINNESOTA ·
Apr 2020 ACTIVE
The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
NATL INST OF HLTH NIGMS · Principal Investigator
Jun 2018 ACTIVE
OR-DRPD-ROF2018: The LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P) Trial
UF RESEARCH · Principal Investigator
Jan 2018 – Dec 2019
Vitamin C, Thiamine and Steroids in Sepsis- multi-center, randomized, placebo-controlled, double-blind, adaptive clinical trial of vitamin C, thiamine and steroids as combination therapy in patients with sepsis.
JOHNS HOPKINS UNIV · Principal Investigator
Apr 2017 ACTIVE
HSC COM Matching Commitment
UNIV OF FLORIDA · Project Manager
Sep 2016 ACTIVE
The Role of Dysfunctional HDL in Sepsis
NATL INST OF HLTH NIGMS · Principal Investigator
Apr 2016 – Mar 2017
TOGETHER: TRANSFORMING AND TRANSLATING DISCOVERY TO IMPROVE ,HEALTH ,
NATL INST OF HLTH NCATS · Project Manager
Jan 2015 – Jan 2018
Dysfunctional HDL Vision
SOCIETY OF CRITICAL CARE MEDICINE · Principal Investigator
Mar 2014 – May 2018
Rapid Administration of Carnitine in Sepsis (RACE)
UNIV OF MISSISSIPPI · Principal Investigator

Education

Emergency Medicine Residency
2006-2010 · Albert Einstein College of Medicine, Bronx, New York
Doctor of Medicine
2002-2006 · Rosalind Franklin University, North Chicago, Illinois

Contact Details

Phones:
Business:
(904) 244-4986
Emails:
Executive Assistant – EM Research:
Amy R Kennedy
View Profile